Patent Information
- (54) Name
- COMBINATION THERAPY INCLUDING AN MDM2 INHIBITOR AND ONE OR MORE ADDITIONAL PHARMACEUTICALLY ACTIVE AGENTS FOR THE TREATMENT OF CANCERS
- (21) Filing number
- PT41191
- (21) EP Number
- 3068393 (open in ep register)
- (51) Classification
- N/A
- Supplementary Protection
- N/A
- (22) Application date
- 22/07/2022
- (24) Registration date
- 29/07/2022
- Expiry date
- 11/11/2023 Renew
- Status
- Expired
- Protection period
- 9
Priority Details
N/A
Applicant Details
| (731) Name / Company | Address | State | Town | Post code | Country |
|---|---|---|---|---|---|
| Amgen Inc. | One Amgen Center Drive Thousand Oaks | California | 91320-1799 | United States |
Inventor Details
N/A
Representative Details
N/A
All Documents
N/A